Skip to main content
Top
Published in: Sleep and Breathing 1/2021

01-03-2021 | Sleep Apnea | Sleep Breathing Physiology and Disorders • Original Article

Demographic, clinical, and biomarker predictors of apnea-hypopnea index from polysomnography in Midwestern sleep clinic patients

Authors: Jennifer N. Miller, Ann M. Berger, Kevin A. Kupzyk

Published in: Sleep and Breathing | Issue 1/2021

Login to get access

Abstract

Background

To examine if selected demographic (age, gender), clinical (diabetes, coronary artery disease, hyperlipidemia, myocardial infarction, stroke, lung disease, smoking history, alcohol intake), and biomarker [blood pressure (BP), heart rate, body mass index (BMI), neck circumference, Mallampati score] variables are predictors of apnea-hypopnea index (AHI) from polysomnography (PSG).

Methods

This cross-sectional study recruited a sample of adults (N = 170) who were being evaluated for OSA. Participants completed self-reported demographic and clinical questionnaires, and then completed PSG (n = 142). Multi-collinearity was assessed. Confounding factors, correlations, and potential interactions were explored.

Results

The final regression model was performed on 130 participants; 61 (46.9%) had an AHI ≥ 15. Systolic and diastolic BPs were highly correlated. Interactions were tested between gender and other variables (high cholesterol, BMI, neck circumference, systolic BP) and between systolic BP and other variables (high cholesterol, BMI, neck circumference, and lung disease). No interactions occurred between gender or systolic BP and other variables, meaning that the effects of the variables on AHI levels from PSG did not vary depending on gender or systolic BP. BMI, systolic BP, and absence of lung disease were predictors for AHI levels ≥ 15 from PSG.

Conclusions

BMI and systolic BP were significant predictors of OSA in this study. The absence of lung disease as a significant predictor was unique and may be due to the small number of participants who self-reported lung disease. To our knowledge, this is the first study to report this combination of variables to predict AHI levels ≥ 15 from PSG.
Literature
1.
go back to reference Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM (2013) Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177:1006–1014CrossRef Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM (2013) Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177:1006–1014CrossRef
2.
go back to reference Berry RB, Brooks R, Gamaldo CE, Harding SM, Lloyd RM, Marcus CL, Vaughn BV (2014) For the American Academy of Sleep Medicine The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. Darien, IL: American Academy of Sleep Medicine; 2014. Version 2.0.3. American Academy of Sleep Medicine: Darien, IL, USA Berry RB, Brooks R, Gamaldo CE, Harding SM, Lloyd RM, Marcus CL, Vaughn BV (2014) For the American Academy of Sleep Medicine The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. Darien, IL: American Academy of Sleep Medicine; 2014. Version 2.0.3. American Academy of Sleep Medicine: Darien, IL, USA
3.
go back to reference Stanley J, Palmisano J, Hoshal S, Binns L, O’Brien L (2018) Age and gender related differences in patient awareness of conditions associated with untreated obstructive sleep apnea. J Sleep Disord Ther 7:2167–0277.1000284 Stanley J, Palmisano J, Hoshal S, Binns L, O’Brien L (2018) Age and gender related differences in patient awareness of conditions associated with untreated obstructive sleep apnea. J Sleep Disord Ther 7:2167–0277.1000284
4.
go back to reference Feng Y, Keenan B, Wang S, Leinwand S, Pack A, Schwab R (2017) New insights into obstructive sleep apnea pathogenesis: dynamic upper airway characteristics during awake respiration in obese subjects with and without obstructive sleep apnea. Am J Respir Crit Care Med 195 Feng Y, Keenan B, Wang S, Leinwand S, Pack A, Schwab R (2017) New insights into obstructive sleep apnea pathogenesis: dynamic upper airway characteristics during awake respiration in obese subjects with and without obstructive sleep apnea. Am J Respir Crit Care Med 195
5.
go back to reference Torres G, Sánchez-de-la-Torre M, Martínez-Alonso M, Gómez S, Sacristán O, Cabau J, Barbé F (2015) Use of ambulatory blood pressure monitoring for the screening of obstructive sleep apnea. J Clin Hypertens 17:802–809CrossRef Torres G, Sánchez-de-la-Torre M, Martínez-Alonso M, Gómez S, Sacristán O, Cabau J, Barbé F (2015) Use of ambulatory blood pressure monitoring for the screening of obstructive sleep apnea. J Clin Hypertens 17:802–809CrossRef
6.
go back to reference Kasai T, Yumino D, Redolfi S, Su M, Ruttanaumpawan P, Mak S, Newton GE, Floras JS, Bradley TD (2015) Overnight effects of obstructive sleep apnea and its treatment on stroke volume in patients with heart failure. Can J Cardiol 31:832–838CrossRef Kasai T, Yumino D, Redolfi S, Su M, Ruttanaumpawan P, Mak S, Newton GE, Floras JS, Bradley TD (2015) Overnight effects of obstructive sleep apnea and its treatment on stroke volume in patients with heart failure. Can J Cardiol 31:832–838CrossRef
7.
go back to reference Lipford MC, Flemming KD, Calvin AD, Mandrekar J, Brown RD Jr, Somers VK, Caples SM (2015) Associations between cardioembolic stroke and obstructive sleep apnea. Sleep 38:1699–1705CrossRef Lipford MC, Flemming KD, Calvin AD, Mandrekar J, Brown RD Jr, Somers VK, Caples SM (2015) Associations between cardioembolic stroke and obstructive sleep apnea. Sleep 38:1699–1705CrossRef
8.
go back to reference Gagnon K, Baril A, Montplaisir J, Carrier J, De Beaumont L, D'Aragon C, Chami S, Pelleieux S, Poirier J, Gauthier S (2019) Disconnection between self-reported and objective cognitive impairment in obstructive sleep apnea. J Clin Sleep Med 15:409–415CrossRef Gagnon K, Baril A, Montplaisir J, Carrier J, De Beaumont L, D'Aragon C, Chami S, Pelleieux S, Poirier J, Gauthier S (2019) Disconnection between self-reported and objective cognitive impairment in obstructive sleep apnea. J Clin Sleep Med 15:409–415CrossRef
9.
go back to reference Iftikhar IH, Hoyos CM, Phillips CL, Magalang UJ (2015) Meta-analyses of the association of sleep apnea with insulin resistance, and the effects of CPAP on HOMA-IR, adiponectin, and visceral adipose fat. J Clin Sleep Med 11:475–485CrossRef Iftikhar IH, Hoyos CM, Phillips CL, Magalang UJ (2015) Meta-analyses of the association of sleep apnea with insulin resistance, and the effects of CPAP on HOMA-IR, adiponectin, and visceral adipose fat. J Clin Sleep Med 11:475–485CrossRef
10.
go back to reference Davies SE, Bishopp A, Wharton S, Turner AM, Mansur AH (2019) The association between asthma and obstructive sleep apnea (OSA): a systematic review. J Asthma 56:118–129CrossRef Davies SE, Bishopp A, Wharton S, Turner AM, Mansur AH (2019) The association between asthma and obstructive sleep apnea (OSA): a systematic review. J Asthma 56:118–129CrossRef
12.
go back to reference Vinnikov D, Blanc PD, Alilin A, Zutler M, Holty JC (2017) Fatigue and sleepiness determine respiratory quality of life among veterans evaluated for sleep apnea. Health Qual Life Outcomes 15:48CrossRef Vinnikov D, Blanc PD, Alilin A, Zutler M, Holty JC (2017) Fatigue and sleepiness determine respiratory quality of life among veterans evaluated for sleep apnea. Health Qual Life Outcomes 15:48CrossRef
13.
go back to reference Qaseem A, Dallas P, Owens DK, Starkey M, Holty JC, Shekelle P (2014) Diagnosis of obstructive sleep apnea in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med 161:210–220CrossRef Qaseem A, Dallas P, Owens DK, Starkey M, Holty JC, Shekelle P (2014) Diagnosis of obstructive sleep apnea in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med 161:210–220CrossRef
14.
go back to reference Heffner JE, Rozenfeld Y, Kai M, Stephens EA, Brown LK (2012) Prevalence of diagnosed sleep apnea among patients with type 2 diabetes in primary care. CHEST J 141:1414–1421CrossRef Heffner JE, Rozenfeld Y, Kai M, Stephens EA, Brown LK (2012) Prevalence of diagnosed sleep apnea among patients with type 2 diabetes in primary care. CHEST J 141:1414–1421CrossRef
15.
go back to reference Lyons OD, Ryan CM (2015) Sleep apnea and stroke. Can J Cardiol 31:918–927CrossRef Lyons OD, Ryan CM (2015) Sleep apnea and stroke. Can J Cardiol 31:918–927CrossRef
16.
go back to reference McNicholas WT (2017) COPD-OSA overlap syndrome: evolving evidence regarding epidemiology, clinical consequences, and management. Chest 152:1318–1326CrossRef McNicholas WT (2017) COPD-OSA overlap syndrome: evolving evidence regarding epidemiology, clinical consequences, and management. Chest 152:1318–1326CrossRef
17.
go back to reference Kolla BP, Foroughi M, Saeidifard F, Chakravorty S, Wang Z, Mansukhani MP (2018) The impact of alcohol on breathing parameters during sleep: a systematic review and meta-analysis. Sleep Med Rev 42:59–67CrossRef Kolla BP, Foroughi M, Saeidifard F, Chakravorty S, Wang Z, Mansukhani MP (2018) The impact of alcohol on breathing parameters during sleep: a systematic review and meta-analysis. Sleep Med Rev 42:59–67CrossRef
18.
go back to reference Schwab RJ, Leinwand SE, Bearn CB, Maislin G, Rao RB, Nagaraja A, Wang S, Keenan BT (2017) Digital morphometrics: a new upper airway phenotyping paradigm in OSA. Chest 152:330–342CrossRef Schwab RJ, Leinwand SE, Bearn CB, Maislin G, Rao RB, Nagaraja A, Wang S, Keenan BT (2017) Digital morphometrics: a new upper airway phenotyping paradigm in OSA. Chest 152:330–342CrossRef
19.
go back to reference Walter RJ, Hagedorn SI, Lettieri CJ (2017) Impact of diagnosing and treating obstructive sleep apnea on healthcare utilization. Sleep Med 38:73–77CrossRef Walter RJ, Hagedorn SI, Lettieri CJ (2017) Impact of diagnosing and treating obstructive sleep apnea on healthcare utilization. Sleep Med 38:73–77CrossRef
20.
go back to reference Scalzitti NJ, O'Connor PD, Nielsen SW, Aden JK, Brock MS, Taylor DM, Mysliwiec V, Dion GR (2018) Obstructive sleep apnea is an independent risk factor for hospital readmission. J Clin Sleep Med 14:753–758CrossRef Scalzitti NJ, O'Connor PD, Nielsen SW, Aden JK, Brock MS, Taylor DM, Mysliwiec V, Dion GR (2018) Obstructive sleep apnea is an independent risk factor for hospital readmission. J Clin Sleep Med 14:753–758CrossRef
21.
go back to reference Collop N, Anderson WM, Boehlecke B, Claman D, Goldberg R, Gottlieb D, Hudgel D, Sateia M, Schwab R (2007) Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. J Clin Sleep Med 3:737–747CrossRef Collop N, Anderson WM, Boehlecke B, Claman D, Goldberg R, Gottlieb D, Hudgel D, Sateia M, Schwab R (2007) Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. J Clin Sleep Med 3:737–747CrossRef
22.
go back to reference Hosmer DW, Lemeshow S (2000) Introduction to the logistic regression model. Applied Logistic Regression, Second Edition 1–30 Hosmer DW, Lemeshow S (2000) Introduction to the logistic regression model. Applied Logistic Regression, Second Edition 1–30
23.
go back to reference Rogers A, Ravenell J, Donat M, Sexias A, Ogedegbe C, McFarlane SI, Jean-Louis G (2015) Predictors of obstructive sleep apnea risk among Blacks with metabolic syndrome. J Obes Overweight 1:1104PubMedPubMedCentral Rogers A, Ravenell J, Donat M, Sexias A, Ogedegbe C, McFarlane SI, Jean-Louis G (2015) Predictors of obstructive sleep apnea risk among Blacks with metabolic syndrome. J Obes Overweight 1:1104PubMedPubMedCentral
24.
go back to reference Kendzerska T, Gershon AS, Hawker G, Leung RS, Tomlinson G (2014) Obstructive sleep apnea and risk of cardiovascular events and all-cause mortality: a decade-long historical cohort study. PLoS Med 11:e1001599CrossRef Kendzerska T, Gershon AS, Hawker G, Leung RS, Tomlinson G (2014) Obstructive sleep apnea and risk of cardiovascular events and all-cause mortality: a decade-long historical cohort study. PLoS Med 11:e1001599CrossRef
25.
go back to reference Pedrosa RP, Drager LF, Gonzaga CC, Sousa MG, de Paula LK, Amaro AC, Amodeo C, Bortolotto LA, Krieger EM, Bradley TD, Lorenzi-Filho G (2011) Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension 58:811–817CrossRef Pedrosa RP, Drager LF, Gonzaga CC, Sousa MG, de Paula LK, Amaro AC, Amodeo C, Bortolotto LA, Krieger EM, Bradley TD, Lorenzi-Filho G (2011) Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension 58:811–817CrossRef
26.
go back to reference Hu X, Fan J, Chen S, Yin Y, Zrenner B (2015) The role of continuous positive airway pressure in blood pressure control for patients with obstructive sleep apnea and hypertension: a meta-analysis of randomized controlled trials. J Clin Hypertens 17:215–222CrossRef Hu X, Fan J, Chen S, Yin Y, Zrenner B (2015) The role of continuous positive airway pressure in blood pressure control for patients with obstructive sleep apnea and hypertension: a meta-analysis of randomized controlled trials. J Clin Hypertens 17:215–222CrossRef
27.
go back to reference Haas DC, Foster GL, Nieto FJ, Redline S, Resnick HE, Robbins JA, Young T, Pickering TG (2005) Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation 111:614–621CrossRef Haas DC, Foster GL, Nieto FJ, Redline S, Resnick HE, Robbins JA, Young T, Pickering TG (2005) Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation 111:614–621CrossRef
28.
go back to reference Krachman SL, Tiwari R, Vega ME, Yu D, Soler X, Jaffe F, Kim V, Swift I, D’Alonzo GE, Criner GJ (2016) Effect of emphysema severity on the apnea–hypopnea index in smokers with obstructive sleep apnea. Ann Am Thoracic Society 13:1129–1135CrossRef Krachman SL, Tiwari R, Vega ME, Yu D, Soler X, Jaffe F, Kim V, Swift I, D’Alonzo GE, Criner GJ (2016) Effect of emphysema severity on the apnea–hypopnea index in smokers with obstructive sleep apnea. Ann Am Thoracic Society 13:1129–1135CrossRef
29.
go back to reference Zidan M, Daabis R, Gharraf H (2015) Overlap of obstructive sleep apnea and bronchial asthma: effect on asthma control. Egypt J Chest Dis Tuberc 64:425–430CrossRef Zidan M, Daabis R, Gharraf H (2015) Overlap of obstructive sleep apnea and bronchial asthma: effect on asthma control. Egypt J Chest Dis Tuberc 64:425–430CrossRef
30.
go back to reference Greenberg-Dotan S, Reuveni H, Tal A, Oksenberg A, Cohen A, Shaya FT, Tarasiuk A, Scharf SM (2014) Increased prevalence of obstructive lung disease in patients with obstructive sleep apnea. Sleep Breath 18:69–75CrossRef Greenberg-Dotan S, Reuveni H, Tal A, Oksenberg A, Cohen A, Shaya FT, Tarasiuk A, Scharf SM (2014) Increased prevalence of obstructive lung disease in patients with obstructive sleep apnea. Sleep Breath 18:69–75CrossRef
Metadata
Title
Demographic, clinical, and biomarker predictors of apnea-hypopnea index from polysomnography in Midwestern sleep clinic patients
Authors
Jennifer N. Miller
Ann M. Berger
Kevin A. Kupzyk
Publication date
01-03-2021
Publisher
Springer International Publishing
Published in
Sleep and Breathing / Issue 1/2021
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-020-02053-w

Other articles of this Issue 1/2021

Sleep and Breathing 1/2021 Go to the issue

Sleep Breathing Physiology and Disorders • Original Article

Practical and rapidly-implemented parameters for assessing APAP titration failure

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.